News Focus
News Focus
Followers 52
Posts 14374
Boards Moderated 0
Alias Born 06/15/2014

Re: Tseven post# 444628

Wednesday, 01/14/2026 11:38:41 AM

Wednesday, January 14, 2026 11:38:41 AM

Post# of 447908
TSeven, I think you have encapsulated my thoughts concerning the new formulation. Without the company providing any details we are left with those thoughts.

Every other company like you say lists their drugs, although the new formulation hasn't even yet gotten a full patent so that has to come first. But you would think that talks with analysts the company would point out what they have coming down the pike.

And, if they don't need extensive trials because it is the same active ingredient (except better absorbed) then knowing insurance companies they will push the cheaper drugs to people, at least force them to at first.

No two ways around it, the company is between a rock and a hard place unless and until they can find a way to shake off the Gs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News